2 mg ETH267 (Doxazosin 2 mg)
Pill imprint 2 mg ETH267 has been identified as Doxazosin mesylate 2 mg.
Doxazosin is used in the treatment of benign prostatic hyperplasia; high blood pressure; raynaud's syndrome and belongs to the drug class antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy. Doxazosin 2 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).
- 2 mg
- Elliptical / Oval
- Prescription only
sodium lauryl sulfate
sodium starch glycolate
D&C Yellow No. 10 Aluminium Lake
|NDC Code||Manufacturer / Repackager|
|67253-0381||DAVA Pharmaceuticals, Inc.|
|54569-5169||A-S Medication Solutions, LLC (repackager)|
|58016-0997||Southwood Pharmaceuticals Inc (repackager)|
|33358-0116||CorePharma, LLC (repackager)|
Note: Inactive ingredients may vary.
More about doxazosin
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.